Immunotherapy

Gemcitabine, Cisplatin, and Nivolumab in bladder cancer: Phase 2 trial.

Sympathetic nerves linked to T cell exhaustion via β1-adrenergic receptor.

Blocking immune checkpoints changes how brain tumors grow.

Isolating and characterizing filamentous fungi with patulin-degrading abilities.

A new hope: Ipilimumab and Nivolumab for resistant melanoma.

Pancreatic cancer survival and the IL6 response to Lorazepam.

Immunotherapy for advanced penile cancer: Global report.

Boosting immune defense against glioblastoma: CTLA-4 blockade's action.

Biphasic JNK-Erk signaling regulates cell senescence after DNA damage

Biomaterial-based immunotherapy shows promise in treating solid tumors.

A new gene delivery and immune cell engineering technology.

The research could lead to better treatments for people with advanced or previously untreatable cancers.